GRCL logo

Gracell Biotechnologies (GRCL) Selling, General & Administrative Expenses

GRCL Annual SG&A

$20.73 M
-$490.90 K-2.31%

31 December 2022

GRCL Selling, General & Administrative Expenses Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

GRCL Quarterly SG&A

$4.38 M
-$948.40 K-17.80%

30 September 2023

GRCL Quarterly SG&A Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

GRCL TTM SG&A

-$1.03 B
-$63.22 M-6.53%

30 September 2023

GRCL TTM SG&A Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

GRCL Selling, General & Administrative Expenses Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-2.3%-17.8%-5264.1%
3 y3 years+423.4%-17.8%-5264.1%
5 y5 years+1235.8%-17.8%-5264.1%

GRCL Selling, General & Administrative Expenses High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year
5 y5-year
alltimeall time-2.3%-33.8%-4730.3%

Gracell Biotechnologies Selling, General & Administrative Expenses History

DateAnnualQuarterlyTTM
Sept 2023
-
$4.38 M(-17.8%)
$19.05 M(-4.7%)
June 2023
-
$5.33 M(+25.4%)
$19.98 M(+5.1%)
Mar 2023
-
$4.25 M(-16.4%)
$19.01 M(-8.3%)
Dec 2022
$20.73 M(-2.3%)
$5.09 M(-4.4%)
$20.72 M(+0.4%)
Sept 2022
-
$5.32 M(+22.2%)
$20.63 M(-5.9%)
June 2022
-
$4.35 M(-27.0%)
$21.93 M(-1.6%)
Mar 2022
-
$5.96 M(+19.2%)
$22.29 M(+5.0%)
Dec 2021
$21.22 M
$5.00 M(-24.5%)
$21.22 M(+6.3%)
DateAnnualQuarterlyTTM
Sept 2021
-
$6.62 M(+40.6%)
$19.96 M(+37.4%)
June 2021
-
$4.71 M(-3.8%)
$14.52 M(+34.5%)
Mar 2021
-
$4.89 M(+30.9%)
$10.80 M(+61.0%)
Dec 2020
$6.60 M(+66.7%)
$3.74 M(+216.2%)
$6.71 M(+63.8%)
Sept 2020
-
$1.18 M(+20.2%)
$4.10 M(+40.6%)
June 2020
-
$983.20 K(+22.0%)
$2.91 M(+50.9%)
Mar 2020
-
$805.70 K(-28.4%)
$1.93 M(+71.6%)
Dec 2019
$3.96 M(+155.2%)
$1.13 M
$1.13 M
Dec 2018
$1.55 M
-
-

FAQ

  • What is Gracell Biotechnologies annual selling, general & administrative expenses?
  • What is the all time high annual SG&A for Gracell Biotechnologies?
  • What is Gracell Biotechnologies annual SG&A year-on-year change?
  • What is Gracell Biotechnologies quarterly selling, general & administrative expenses?
  • What is the all time high quarterly SG&A for Gracell Biotechnologies?
  • What is Gracell Biotechnologies quarterly SG&A year-on-year change?
  • What is Gracell Biotechnologies TTM selling, general & administrative expenses?
  • What is the all time high TTM SG&A for Gracell Biotechnologies?
  • What is Gracell Biotechnologies TTM SG&A year-on-year change?

What is Gracell Biotechnologies annual selling, general & administrative expenses?

The current annual SG&A of GRCL is $20.73 M

What is the all time high annual SG&A for Gracell Biotechnologies?

Gracell Biotechnologies all-time high annual selling, general & administrative expenses is $21.22 M

What is Gracell Biotechnologies annual SG&A year-on-year change?

Over the past year, GRCL annual selling, general & administrative expenses has changed by -$490.90 K (-2.31%)

What is Gracell Biotechnologies quarterly selling, general & administrative expenses?

The current quarterly SG&A of GRCL is $4.38 M

What is the all time high quarterly SG&A for Gracell Biotechnologies?

Gracell Biotechnologies all-time high quarterly selling, general & administrative expenses is $6.62 M

What is Gracell Biotechnologies quarterly SG&A year-on-year change?

Over the past year, GRCL quarterly selling, general & administrative expenses has changed by -$948.40 K (-17.80%)

What is Gracell Biotechnologies TTM selling, general & administrative expenses?

The current TTM SG&A of GRCL is -$1.03 B

What is the all time high TTM SG&A for Gracell Biotechnologies?

Gracell Biotechnologies all-time high TTM selling, general & administrative expenses is $22.29 M

What is Gracell Biotechnologies TTM SG&A year-on-year change?

Over the past year, GRCL TTM selling, general & administrative expenses has changed by -$1.05 B (-5264.11%)